Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
· barrons.com · popularity 19/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at barrons.com →
Summary
Genmab shares rocketed toward their best session on record Wednesday after trial data showed an experimental cancer therapy slashed the risk of …
Found in: Investing. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 9.